Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4798946
Max Phase: Preclinical
Molecular Formula: C30H36ClN7O3
Molecular Weight: 578.12
Molecule Type: Unknown
Associated Items:
ID: ALA4798946
Max Phase: Preclinical
Molecular Formula: C30H36ClN7O3
Molecular Weight: 578.12
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)(C)CN1Cc2c(cc(Cl)c3[nH]ncc23)C[C@@H](NC(=O)N2CCC(N3Cc4ccccc4NC3=O)CC2)C1=O
Standard InChI: InChI=1S/C30H36ClN7O3/c1-30(2,3)17-37-16-22-19(12-23(31)26-21(22)14-32-35-26)13-25(27(37)39)34-28(40)36-10-8-20(9-11-36)38-15-18-6-4-5-7-24(18)33-29(38)41/h4-7,12,14,20,25H,8-11,13,15-17H2,1-3H3,(H,32,35)(H,33,41)(H,34,40)/t25-/m1/s1
Standard InChI Key: FPMAPYXWIROABY-RUZDIDTESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 578.12 | Molecular Weight (Monoisotopic): 577.2568 | AlogP: 4.74 | #Rotatable Bonds: 3 |
Polar Surface Area: 113.67 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.97 | CX Basic pKa: 1.62 | CX LogP: 2.86 | CX LogD: 2.86 |
Aromatic Rings: 3 | Heavy Atoms: 41 | QED Weighted: 0.42 | Np Likeness Score: -0.90 |
1. Mercer SE,Chaturvedula PV,Conway CM,Cook DA,Davis CD,Pin SS,Macci R,Schartman R,Signor LJ,Widmann KA,Whiterock VJ,Chen P,Xu C,Herbst JJ,Kostich WA,Thalody G,Macor JE,Dubowchik GM. (2021) Azepino-indazoles as calcitonin gene-related peptide (CGRP) receptor antagonists., 31 [PMID:33096162] [10.1016/j.bmcl.2020.127624] |
Source(1):